Navigation Links
Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
Date:5/3/2012

THE WOODLANDS, Texas, May 3, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

LX4211, a dual inhibitor of sodium glucose transporter 1 and 2 (SGLT1 and SGLT2), was designed to improve control of blood glucose through mechanisms that do not require the pancreas to produce insulin. In type 1 diabetes, also called juvenile diabetes, the pancreas stops producing enough insulin to support life. People with type 1 diabetes must monitor their blood sugar levels through frequent measures of blood glucose in order to select and administer doses of insulin via shots or an insulin pump, multiple times every day. With current insulin therapies, even vigilant management of blood sugar does not eliminate the risk of type 1 diabetes complications such as heart attack, stroke, blindness, and kidney failure.

"Results we have obtained to date with LX4211 encourage us to expand its potential application to both type 1 and type 2 diabetes, a unique opportunity for an oral therapy," said Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer. "In this new trial, we hope to see significant reductions in the amount of insulin required by type 1 patients as well as more consistent blood sugar control."

LX4211 has already demonstrated beneficial effects on glucose control in clinical trials conducted to date in type 2 diabetes, or adult-onset diabetes. Studies have shown that LX4211 lowers blood sugar levels after meals, reducing glucose absorption from the gastrointestinal tract and triggering the production of beneficial hormones s
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 According to ... (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, ... Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market ... 411.5 Million in 2015, at a CAGR of 11.4 % from ... ma rket data T ables and ...
(Date:8/27/2015)... 2015   Proxsys Rx, the nation,s ... expanding its population health management services with ... care program for hospitals and health systems. ... with technology systems and pharmacy support services ... been mandated by Center for Medicare and ...
(Date:8/27/2015)... -- NorthStar Anesthesia , one of the country,s leading ... by Mercy, based in Toledo, Ohio , ... Mercy St. Vincent  Medical Center and Mercy St. Anne ... Charles  Hospital in Oregon and ... "As we looked to create a more organized ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2Four Mercy Hospitals in Northwest Ohio Select NorthStar Anesthesia 2
... an urgent need for more,comprehensive lipid control to protect ... A new 30-year analysis of the,National Health and Nutrition ... (NLA) indicates that while,Americans are doing a better job ... with high triglycerides, a blood fat linked to heart,disease, ...
... Nov. 7 Data from an investigational,open-label, ... (Epoetin alfa) in treating anemia in subjects ... (CKD) were presented today at the American ... three dosing groups, including the FDA-approved,three-times-per-week (TIW) ...
Cached Medicine Technology:New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 2New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
(Date:8/28/2015)... RESTON, Va. (PRWEB) , ... August 28, 2015 ... ... Innovation , which is dedicated to distributing health information technology innovation to transform ... industry survey. Results of the survey will be de-identified and aggregated before being ...
(Date:8/28/2015)... ... August 28, 2015 , ... United Benefit Advisors ... TJS Insurance Group as its newest Partner Firm. Founded in 1924 and headquartered ... them focused on their goals. Within the past 10 years, TJS Insurance Group ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs Steering Committee (PSC) ... Testosterone Replacement Therapy Products Liability Litigation, are in the midst of ongoing discussion ... PSC may receive for corporate employees involved in the production or marketing of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Inc. magazine today ranked ... an exclusive ranking of the nation’s fastest-growing private companies. The list was unveiled online ... growth of 85% over the last three years, PREVENT ranks higher on the list ...
(Date:8/28/2015)... ... August 28, 2015 , ... Where can successful, well ... MillionaireMatchmakerOnline.net is set up to help quality singles find dating partners or ideal ... are rich, gorgeous, well educated, or attractive. , It updates profiles under the ...
Breaking Medicine News(10 mins):Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3
... FARMINGTON HILLS, Mich., Aug. 14 Work and economy related ... to a new independent survey conducted by American Laser Centers, the ... half of the respondents who took part in the survey (47 ... no stress. , , The physical ...
... NOVATO, Calif., Aug. 14 Purple Communications, Inc. (Nasdaq: ... and professional interpreting for deaf, hard of hearing, and speech impaired ... 2009. On August 13, 2009, the Company filed with the Securities ... the quarter ended June 30, 2009. , , ...
... , , , ... implementation of successful payment strategies enables the North American home ... achieve double digit growth in the traditionally mature patient monitoring ... mature market is the increasing incidence of cardiovascular disease (CD) ...
... findings published in the August issue of the Journal ... use of magnetic resonance imaging (MRI) as a means to ... Researchers found that women diagnosed with breast cancer who received ... breast conserving therapy (BCT), and may face delays in treatment. ...
... , , BELLEVUE, Wash., Aug. ... solutions, today announced the new Edifecs5010(TM) Compliance ... and services for healthcare providers, payers, health plans, ISVs, and clearinghouses ... , , Edifecs, the gold standard for HIPAA ...
... , RICHMOND, Calif., Aug. 14 ... specialty pharmaceutical company focused on the development and commercialization of ... announced financial results for the three and six months ended ... Oclassen, President and Chief Executive Officer commented, "Our recently announced ...
Cached Medicine News:Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 2Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 3Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 4Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 5Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 6Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 7Health News:Purple Communications(TM) Announces Second Quarter 2009 Results 8Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 2Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 3Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 4Health News:MRI may be unnecessary prior to treatment in most newly diagnosed breast cancer patients 2Health News:Edifecs Launches the Edifecs5010(TM) Compliance Suite of Tools, Resources and Services for 5010 Migration. 2Health News:Edifecs Launches the Edifecs5010(TM) Compliance Suite of Tools, Resources and Services for 5010 Migration. 3Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 2Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 3Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 4Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 5Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 6Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 7Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 8Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 9Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 10Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 11Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 12Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 13
This high-capacity stand-on scale provides extra sensitivity and support to patients who are unsteady on their feet. Advanced technology compensates for patient movement....
... new screening, diagnostic, treatment assessment and patient ... sleep-related breathing disorders. The Watch-PAT 100 is ... an ambulatory, reliable, patient friendly diagnostic evaluation ... number of OSA sufferers, and to the ...
... synthesized by the parathyroid glands [1,2] ... extracellular calcium concentrations. PTH prevents hypocalcemia ... calcium excretion by the kidney. Following ... is rapidly degraded into 4 fragments: ...
... Dehydroepiandrosterone (DHEA) is produced in the ... the gonads [1,2,3]. DHEA serves as a ... has relatively weak androgenic activity, estimated at ... neonates, peripubertal children and in adult women, ...
Medicine Products: